Skip to main content
News

Rockville biotech snags $220M for biodefense center

By June 19, 2012No Comments
emergent biosolutions

emergent biosolutions

Emergent BioSolutions, the Rockville biotech that sells the only approved anthrax vaccine to the federal government, has won a $220 million grant to establish a new biodefense development and manufacturing center in Maryland.

The Center for Innovation in Advanced Development and Manufacturing is designed to develop a range of medical countermeasures to biological, radiological and nuclear threats. It also will ensure the capability to produce vaccines for pandemic influenza and provide work force development programs for federal needs, according to a company statement.

To read the full, original article click on this link: Gazette.Net: Rockville biotech snags $220M for biodefense center

{iframe}http://www.gazette.net/article/20120618/NEWS/706189974/1033/rockville-biotech-snags-220m-for-biodefense-center&template=gazette{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.